CO-DIAGNOSTICS DL-,001 Forum: Community User: tms33
On October 28, 2025, analyst Jason Kolbert from D. Boral Capital has maintained his 'Buy' rating for Co-Diagnostics (CODX). The price target remains steady at $3.00, showing no change from the previous evaluation. This position reflects a continued positive outlook for the stock, according to the analyst's report.
On October 28, 2025, analyst Jason Kolbert from D. Boral Capital has maintained his 'Buy' rating for Co-Diagnostics (CODX). The price target remains steady at $3.00, showing no change from the previous evaluation. This position reflects a continued positive outlook for the stock, according to the analyst's report.
|
|
Thema | ||
|---|---|---|---|
| 1 | Trading- und Aktien-Chat | ||
| 2 | IPO CSG | -2,48 % | |
| 3 | ATOS Hauptdiskussion | +4,33 % | |
| 4 | Renk und alles was dazugehört | -4,06 % | |
| 5 | Canopy Hauptforum | -1,71 % | |
| 6 | Virgin Galactica | -8,96 % | |
| 7 | Battalion | -8,80 % | |
| 8 | NEL ASA Hauptdiskussion | -0,70 % | |
| 9 | enCore Energy Hauptdiskussion | +13,24 % | |
| 10 | NOKIA Hauptdiskussion | -0,57 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | IPO CSG | -2,48 % | |
| 2 | ATOS Hauptdiskussion | +4,33 % | |
| 3 | Renk und alles was dazugehört | -4,06 % | |
| 4 | Canopy Hauptforum | -1,71 % | |
| 5 | Virgin Galactica | -8,96 % | |
| 6 | Battalion | -8,80 % | |
| 7 | Hims & Hers Health Registered (A) Hauptdiskussion | +12,49 % | |
| 8 | enCore Energy Hauptdiskussion | +13,24 % | |
| 9 | Security der nächsten Generation | +14,04 % | |
| 10 | NEL ASA Hauptdiskussion | -0,70 % | Alle Diskussionen |